Keith Gottesdiener
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Trypanosoma species research and implications, Regulation of Appetite and Obesity, Pharmacogenetics and Drug Metabolism, Diabetes Treatment and Management
Most-Cited Works
- → Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial(2008)1,695 cited
- → Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization(2002)567 cited
- → Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes(2006)499 cited
- → Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist(2016)464 cited
- → [18F]MK-9470, a positron emission tomography (PET) tracer forin vivohuman PET brain imaging of the cannabinoid-1 receptor(2007)313 cited
- → MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency(2018)300 cited
- → Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency(2017)290 cited
- → Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies(2007)276 cited
- → Antagonism of the prostaglandin D 2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans(2006)268 cited
- → Effect of Sitagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension(2008)211 cited